Dong Y. Hua

299 Qingyang Road
Wuxi, 214023, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 158 publications

Corrigendum to "Orai1 is critical for notch-driven aggressiveness under hypoxic conditions in triple-negative breast cancers" [Biochim Biophys Acta Mol Basis Dis 2018 Apr;1864(4 Pt A):975-986].

Corrigendum to "Orai1 is critical for notch-driven aggressiveness under hypoxic conditions in triple-negative breast cancers" [Biochim Biophys Acta Mol Basis Dis 2018 Apr;1864(4 Pt A):975-986].

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: May 26, 2026

Industrializing traditional medical knowledge in China: an integrated governance framework for addressing institutional fragmentation.

Industrializing traditional medical knowledge in China: an integrated governance framework for addressing institutional fragmentation.

Journal: Frontiers in public health

Published: May 24, 2026

Member selection in traditional Chinese medicine innovation consortia: an evolutionary game theory approach.

Member selection in traditional Chinese medicine innovation consortia: an evolutionary game theory approach.

Journal: Frontiers in medical technology

Published: January 13, 2026

Erratum: Cold atmospheric plasmas target breast cancer stemness via modulating AQP3-19Y mediated AQP3-5K and FOXO1 K48-ubiquitination: Erratum.

Erratum: Cold atmospheric plasmas target breast cancer stemness via modulating AQP3-19Y mediated AQP3-5K and FOXO1 K48-ubiquitination: Erratum.

Journal: International journal of biological sciences

Published: January 05, 2026

Metformin enhances survival with immune checkpoint inhibitors in cancer patients: A meta-analysis.

Metformin enhances survival with immune checkpoint inhibitors in cancer patients: A meta-analysis.

Journal: Oncology letters

Published: December 15, 2025

Policy and legal perspectives on the traditional Chinese medicine varietal protection system (TCMVPS): reform or abolition?

Policy and legal perspectives on the traditional Chinese medicine varietal protection system (TCMVPS): reform or abolition?

Journal: Frontiers in pharmacology

Published: October 16, 2025

Promoting endogenous iron mediated ferroptosis for cancer therapy through gene interference and reactive oxygen species amplification.

Promoting endogenous iron mediated ferroptosis for cancer therapy through gene interference and reactive oxygen species amplification.

Journal: Journal of colloid and interface science

Published: August 31, 2025

Fabrication of docetaxel-loaded PEG-modified calcium carbonate-loaded zeolite imidazole nanoframeworks for synergic gastric cancer photothermal therapy.

Fabrication of docetaxel-loaded PEG-modified calcium carbonate-loaded zeolite imidazole nanoframeworks for synergic gastric cancer photothermal therapy.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: August 29, 2025

FKBP9 Enhances Colon Cancer Cell Proliferation by Inhibiting GPX4-Mediated Ferroptosis.

FKBP9 Enhances Colon Cancer Cell Proliferation by Inhibiting GPX4-Mediated Ferroptosis.

Journal: Cancer medicine

Published: August 27, 2025

Investigating the causal link between metformin and lung cancer risk: a two-sample mendelian randomization analysis.

Investigating the causal link between metformin and lung cancer risk: a two-sample mendelian randomization analysis.

Journal: BMC cancer

Published: August 20, 2025

Upregulation of spondin-2 indicates poorer clinical outcomes and induces radioresistance in gastric cancer.

Upregulation of spondin-2 indicates poorer clinical outcomes and induces radioresistance in gastric cancer.

Journal: Translational cancer research

Published: August 04, 2025

Safety and preliminary efficacy results of IBI389, an anti-Claudin18.2×CD3 bispecific antibody, in patients with solid tumors and gastric or gastro-esophageal tumors: a phase 1 dose escalation and expansion study.

Safety and preliminary efficacy results of IBI389, an anti-Claudin18.2×CD3 bispecific antibody, in patients with solid tumors and gastric or gastro-esophageal tumors: a phase 1 dose escalation and expansion study.

Journal: BMC medicine

Published: July 30, 2025

Showing 1-12 of 158

Last Updated: 09/26/2026